The $455 Million Forever-Chemicals Bill Is Really a Chemours Story

The oddest part of the $455 million "forever chemicals" settlement that DuPont, Chemours and Corteva reached with North Carolina last week isn't the $455 million. It's the $135 million that nobody is getting.

That $135 million is a reserve that DuPont and Corteva will set aside, which North Carolina can reach into only if Chemours goes bankrupt or otherwise stops being able to honor its cleanup obligations under a 2019 consent order with the state. No one is paid from it unless the weakest of the three companies fails. It is the state's way of requiring a solvent signature, and it is worth pausing on, because it tells you who this deal is actually about.

First, the genealogy, because "DuPont, Chemours and Corteva" reads like three companies but is really one company that split. The original E.I. du Pont de Nemours spun off its performance-chemicals business — the Teflon and related PFAS operations — as Chemours in 2015. Then in 2017 DuPont merged with Dow into a single DowDuPont, which in 2019 split into Dow, a new DuPont, and the agriculture company Corteva. So the PFAS liability that old DuPont acquired over decades of making a class of chemicals at its Fayetteville Works plant in North Carolina now has to be shared among three separately listed companies.

They did not agree on how. The 2015 spin-off came with a separation agreement that leaned on Chemours to indemnify DuPont for the legacy liabilities, and the companies spent years in disputes "originating from the 2015 spin-off of Chemours." In January 2021 they signed a binding memorandum of understanding to stop fighting and fix the split: Chemours bears 50% of qualified PFAS expenses, DuPont and Corteva bear the other 50%, over a 20-year arrangement capped at $4 billion in qualified spend (DuPont and Corteva's combined share capped at $2 billion), backed by a $1 billion escrow account.

That 2021 contract is what did the work here. Because the North Carolina settlement — $455 million of direct payments to the state and 11 local governments on the Cape Fear River, paid out over 10 to 15 years — is simply allocated the way the 2021 deal says all PFAS bills are allocated. Chemours pays half. DuPont and Corteva split the other half among themselves under their own agreement. When state officials quote a $590 million total, they are adding the $455 million of direct payments to the $135 million reserve that mostly just sits there.

Now materiality, because the three companies are very different sizes. DuPont has a market cap around $17 billion. Corteva's is around $56 billion. Their shares of this settlement are rounding errors, spread over a decade and a half. Chemours is the real party: its market cap is about $2.3 billion, it is not currently profitable, and this is on top of the roughly $1.2 billion it says it has already spent complying with that 2019 consent order — testing some 27,500 private wells, filtering water for thousands of households, building treatment systems. Its share of the direct settlement, roughly $227 million over 15 years, is small change next to that. Chemours says it expects to pay about $50 million in the next twelve months.

That is the sense in which the $135 million reserve is the revealing detail. The deal inverts the usual structure: the two richest descendants of old DuPont, each far less guilty of the actual pollution at Fayetteville, are guaranteeing a cleanup obligation that belongs mostly to Chemours. North Carolina wanted a backstop behind the financially thinnest of the three, so it took a contingent claim on the two healthy ones instead of a personal promise from the one doing the cleaning. That is what a reserve of this kind is: a credit tripwire that tells you who the state trusts to still be there when the bill comes due.

The other thing the reserve and the caps tell you is that this is not the last PFAS bill. The $4 billion limit in the 2021 agreement applies only to a defined bucket of "qualified" expenses. The 2023 settlement that resolved the big federal drinking-water class action — $1.185 billion, split Chemours $592 million, DuPont $400 million, Corteva $193 million — explicitly left out state attorneys general's natural-resource-damage claims and personal-injury claims. North Carolina's own attorney general is still pursuing six cases tied to PFAS in firefighting foam, and a separate suit by the Cape Fear Public Utility Authority in Wilmington is still open. And the truly distant tail is worth noting: under the 2021 deal, once the $4 billion cap is reached, Chemours' original indemnification obligations under the 2015 separation agreement "continue unchanged" — meaning the heaviest residual exposure, the part beyond the box the three companies drew around themselves, lands back on the smallest balance sheet.

So read the headline the way it deserves. This is not a DuPont story or really a Corteva story, and it is not even a huge number. It is a Chemours story — another pin in a company that is already the most PFAS-burdened of the three, with the thinnest equity cushion and, because of that reserve, the one the state looked at and decided it didn't quite trust to still be solvent. The settlement clears a piece of ground. It does not end the game, and for Chemours the game is the point.